Categories

Above the Fold

Announcing the GuideWell Matchmaking Summit

SPONSORED POST

By CATALYST @ HEALTH 2.0

GuideWell Innovation, in collaboration with Catalyst @ Health 2.0, is thrilled to announce the opening of applications for the GuideWell Matchmaking Summit – a new corporate/investor matchmaking event hosted at the GuideWell Innovation Center in Orlando, FL on August 29-30, 2019.

This exciting opportunity connects established healthcare organizations and investors with growing health technology companies. Through professionally curated meetings, the event is designed to encourage synergistic relationships while promoting the testing, commercialization, financing and adoption of innovative digital health tools. Meetings are arranged based on participating organizations’ needs and areas of expertise, allowing for the cultivation of diverse partnership opportunities between digital health innovators, healthcare corporations, and investors that support the growing digital health ecosystem.

The GuideWell Matchmaking Summit is a 2-day event that will be held at the GuideWell Innovation Center in Orlando, FL. The first day of the Summit will be a corporate matchmaking opportunity for invited scale up health technology companies to meet with healthcare organizations that are qualified customer prospects. participants will have a series of meetings that are arranged based on “matched” areas of focus. Innovators will have the opportunity to demo their technology, detail their value proposition, and discuss business avenues with potential partners. Concurrently, healthcare leaders can identify up-and-coming digital health products to utilize at their organizations.

The second day of the Summit will be an investor showcase/matchmaking event for invited health technology scale ups to connect with a national network of venture capitalists. Scale up health technology companies will be competitively selected to attend the Summit based on customer/investor fit with attending corporations and investors.

Continue reading…

What’s After Health 2.0? Trends Shaping Health Tech | Indu Subaiya, Health 2.0 & Catalyst Health

By JESSICA DAMASSA, WTF HEALTH

“Renaissance woman” and Catalyst Health President & Senior Advisor for HIMSS, Indu Subaiya, has spent the past 13 years tracking the growth and integration of digital health and health technology into healthcare systems worldwide. So, how have things evolved over time? What’s new and changing? Indu points out some of the differences she’s seeing in the European approach to healthcare’s ‘digital transformation’ (hint: they’re winning at clinician engagement) and explains what startups around the world should be focused on to remain relevant as Big Tech companies infiltrate the space.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Helping Health Tech Developers Connect to Connected Devices | Friedrich Lämmel, Thryve

By JESSICA DAMASSA, WTF HEALTH

Thryve has created a “connection point” for all different data sources that varies from other companies.Friedrich Lämmel explains the problem behind having just one data source and how the company makes it easier for companies make it more accessible for patients. Startups looking for a fast way to get access to hundreds of data points from top wearables, sensors, and tracking devices need look no further than Thryve. A single SDK point for accessing a bunch of health data, the company has taken the friction out of connecting to connected devices for developers in more ways than one. Friedrich Lämmel talks about all the ‘magic’ of Thryve and about winning the EC2VC competition at HIMSS/Health 2.0 Europe.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Can an App Help You Lose Weight? | André Heikius, Edevent

By JESSICA DAMASSA, WTF HEALTH

Can an app help you lose weight? Chairman & Medical Director for Edevent, Andre Heikius, thinks so. Billed as a ‘digital solution for obesity,’ Edevent is an app that offers professional weight loss advice 24-7 via a conversational algorithm that’s been designed to help people better understand the factors behind their weight gain. Are you eating too late at night? Are you an emotional eater? Find out how the app leverages evidence-based guidelines to help people make a difference on their waistlines.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Can You Treat IBS with an App? | Jossy Onwude of Bold Health

By JESSICA DAMASSA, WTF HEALTH

Bold Health hopes to help the millions that suffer with IBS (Irritable Bowel Syndrome) by providing a fully digital solution that is “as effective” as the drugs currently prescribed to treat the condition. Jossy Onwude, Chief Medical & Product Officer for Bold Health, explains how the company has created a digital therapeutic for delivering the NHS protocol for treating IBS and is currently working on clinical validation trials with some big-name partners.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Price-Fixing Case Reveals Vulnerability of Generic Drug Policies

By ANDREW MULCAHY

A massive lawsuit filed in May by 44 states accuses 20 major drug makers of colluding for years to inflate prices on more than 100 generic drugs, including those to treat H.I.V., cancer and depression. If true, the alleged behavior is not just a violation of antitrust law, but also a betrayal of the government policies that created and defended the entire generic drug industry. 

Most prescriptions in the U.S. today — 9 in 10 — are filled with generics, which are just as safe and effective as their brand-name equivalent. And yet generics account for only 22 percent of U.S. prescription drug spending. These prices are so low because of competition between makers of different versions of the same generic drug. The more competing generic alternatives, the lower the price, theoretically right down to the marginal cost of manufacturing the pill. 

This success is the result of decades of careful federal and state policymaking, all geared towards introducing competition in prescription drug markets. The entire generic industry has its origins in the Hatch-Waxman Act of 1984. Prior to Hatch-Waxman, a company that wanted to sell a competing version of a drug whose patents had expired had to conduct lengthy and expensive clinical trials to get approval from the U.S. Food and Drug Administration. Hatch-Waxman established a quicker, less-expensive path to FDA approval that leans on the scientific research supporting the already approved brand-name drugs.  

Hatch-Waxman also created incentives for generic drug makers to challenge drug patents that prevent competition. Successful challengers win a 180-day period of exclusivity during which their generic is the only one allowed to compete with the brand-name drug. The floodgates open and additional competition pushes prices down further after the 180-day period.  

Continue reading…

Redefining STI & HIV Testing in the Netherlands | Erwin Fisser, Soa Aids Nederland

By JESSICA DAMASSA, WTF HEALTH

Soa Aids Nederland is a unique NGO in the Netherlands that is helping people get STI and HIV tests delivered directly to their homes. A government-funded NGO, the organization has created an extensive online questionnaire that is not only collecting data on sexual health, but also discreetly deploying testing kits to those who want a more private way to check for STIs. Erwin Fisser explains what’s next for the service — and the data that the extensive questionnaire is collecting.

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

Landmark Results Achieved in Aging and Chronic Disease: Danish Group Extends Disease-free Life by 8 Years

By WILLIAM H. BESTERMANN JR., MD

New Scientific Breakthroughs Can Provide a Longer Healthier Life

Twenty-one years of follow-up comparing usual care with a protocol-driven team-based intervention in diabetes proved that healthy life in humans can be prolonged by 8 years. These results were achieved at a lower per patient per year cost. Aging researchers have been confident that we will soon be able to prolong healthy life. This landmark study shows this ambitious goal can be achieved now with lifestyle intervention and a few highly effective proven medications. These medications interfere with the core molecular biology that causes chronic disease and aging. These same medications will likely produce similar results in patients with congestive heart failure, chronic kidney disease, arterial disease, history of heart attack, hypertension, and angina. Simple medical interventions can extend healthy lifespan today.

Better Chronic Disease Management Can Improve Health and Lower Costs

90% of health care costs come from chronic diseases and aging which are both related. The same biochemistry that causes aging causes chronic disease. Eating processed food, gaining weight, smoking cigarettes, and sitting on the couch accelerate aging and chronic condition development. Those activities switch on genes that should be quiet. Eating real food, avoiding cigarettes, activity, lisinopril, losartan, atorvastatin, metformin, (and spironolactone) are now proven to extend healthy life by 8 years in patients who are at high risk of health catastrophes and early death! These medications all cost $4 a month except for atorvastatin which is $9 a month. The benefits continue even when best practice treatment stops probably because these treatments block signaling from dangerous genes that are inappropriately and persistently turned on.

Progress Will Require Extensive Health System Reengineering

Having better health and reducing health care costs can happen today. Surprisingly, the biggest barrier to progress is our current health care system. It is arranged around catastrophes, organ systems, and hospitals. These concepts are 100 years old. Chronic disease begins decades before the catastrophe, and it is related to aging. Age is the greatest risk factor for a heart attack. The same biochemistry that causes accelerated aging also causes heart attack and strokes. It makes little sense to see a cardiologist for a heart attack and a neurologist for a stroke. They are caused by the same molecular biology. The leading health care systems are beginning to recognize that. The interventions that slow aging and chronic diseases development impact every cell in the body. Every young person who is overweight or smokes has activated genes that make accelerated aging and chronic disease more likely. If these genes are switched on prior to having children, that risk is passed on to the next two generations.

Primary care teams organized to address chronic conditions and more rapid aging will provide lifestyle advice and medication that interfere directly with the biology that is causing the problem. The further upstream these individuals are when identified, the easier it is to slow aging and delay chronic disease onset. The path to better health at lower cost lies in the outpatient setting with primary care teams that are well-versed in molecular biology.

Continue reading…

What’s the Difference Between ‘Digital Therapeutics’ & ‘Digital Drugs’? | Lina Behrens Flying Health

By JESSICA DAMASSA, WTF HEALTH

As a new crop of ‘digital therapeutics’ begins to redefine the Future of Pharma, health tech startups and their partners are starting to further refine how they explain (and clinically validate) the outcomes associated with their technologies. So, what’s the difference between a ‘digital drug’ and a ‘digital therapeutic’? Flying Health’s Director of Digital Drugs, Lina Behrens, explains…

Filmed at HIMSS/Health 2.0 Europe in Helsinki, Finland in June 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew HoltGet a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.

India’s Mob Problem

By SAURABH JHA, MD

Recently, my niece gingerly confided that she was going to study engineering rather than medicine. I was certain she’d become a doctor – so deep was her love for biology and her deference to our family tradition. But she calculated, as would anyone with common sense, that with an engineering degree and an MBA, she’d be working for a multinational company making a comfortable income by twenty-eight. If she stuck with tradition and altruism, as a doctor she’d still be untrained and preparing for examinations at twenty-eight.

Despite the truism in India that doctors are the only professionals never at risk of starving, the rational case for becoming a physician never was strong. Doctors always needed a dose of the irrational, an assumption of integrity and an unbridled goodwill to keep going. Once, doctors commanded both the mystery of science and the magic of metaphysics. As medicine became for-profit, the metaphysics slowly disappeared.

Indians are becoming more prosperous. They’re also less fatalistic and expect less from their gods and more from their doctors. In the beginning they treated their doctors as gods, now they see that doctors have feet of clay, too. Doctors, who once outsourced the limitations of medicine to the will of Gods, summarized by the famous Bollywood line “inko dawa ki nahin dua ki zaroorat hai” (patient needs prayers not drugs), now must internalize medicine’s limitations. And there are many – medicine is still an imperfect science, a stubborn art, often an optimistic breeze fighting forlornly against nature’s implacable gale.

Continue reading…

assetto corsa mods